These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 2739356)
1. [Excretion of N-acetyl-beta-D-glucosaminidase in the urine of children with type I juvenile diabetes mellitus and of patients treated with the aminoglycoside amikacin]. Wiesmann U; Peheim E; Colombo JP Klin Wochenschr; 1989; 67 Suppl 17():40-3. PubMed ID: 2739356 [TBL] [Abstract][Full Text] [Related]
2. [Urinary proteins in patients with diabetes mellitus]. Hofmann W; Guder WG Klin Wochenschr; 1989; 67 Suppl 17():37-9. PubMed ID: 2472508 [TBL] [Abstract][Full Text] [Related]
3. [The excretion of N-acetyl-beta-D-glucosaminidase in the urine of children with urinary tract diseases]. Zandvliet EE; Giesberts MA; van Gelderen HH Tijdschr Kindergeneeskd; 1983 Aug; 51(4):135-8. PubMed ID: 6670088 [TBL] [Abstract][Full Text] [Related]
4. [An early and specific indicator of aminoglycoside nephrotoxicity: isoenzyme B of urinary N-acetyl-beta-D-glucosaminidase (NAG)]. Gibey R; Dupond JL; Peltier H; Iehl-Robert M; Henry JC Pathol Biol (Paris); 1986 May; 34(5):342-5. PubMed ID: 3534703 [TBL] [Abstract][Full Text] [Related]
5. [Assessment of the nephrotoxicity of amikacin in patients with cystic fibrosis]. Hügli R; Artho G; Wiesmann UN; Peheim E; Schaad UB; Bianchetti MG Schweiz Med Wochenschr; 1992 Jun; 122(24):930-5. PubMed ID: 1377401 [TBL] [Abstract][Full Text] [Related]
6. Obstructed versus dilated nonobstructed kidneys in children with congenital ureteropelvic junction narrowing: role of urinary tubular enzymes. Taha MA; Shokeir AA; Osman HG; Abd El-Aziz Ael-A; Farahat SE J Urol; 2007 Aug; 178(2):640-6. PubMed ID: 17574624 [TBL] [Abstract][Full Text] [Related]
7. [Excretion of beta-N-acetylglucosaminidase in urine in type I and type II diabetic patients with and without nephropathy]. Werle E; Bostedt A; Fiehn W; Hasslacher C Wien Klin Wochenschr Suppl; 1991; 189():59-62. PubMed ID: 1962487 [TBL] [Abstract][Full Text] [Related]
8. Urine and serum leucine aminopeptidase, N-acetyl-beta-glucosaminidase and gamma-glutamyl transpeptidase activities in diabetics with and without nephropathy. Cohen N; Gertler A; Atar H; Bar-Khayim Y Isr J Med Sci; 1981 Jun; 17(6):422-5. PubMed ID: 6114940 [TBL] [Abstract][Full Text] [Related]
9. Urinary N-acetyl-beta-D-glucosaminidase (NAG) in aminoglycoside nephrotoxicity. Assadamongkol K; Tapaneya-Olarn W; Chatasingh S J Med Assoc Thai; 1989 Jan; 72 Suppl 1():42-6. PubMed ID: 2732646 [TBL] [Abstract][Full Text] [Related]
10. [Urinary excretion of N-acetyl-beta-D-glucosaminidase and microglobulin 2 in type I diabetes mellitus]. Sitjar de Togores Alvarez M; Muros de Fuentes M; León López C; García Nieto VM; López Mora E; Rial Rodríguez JM; Rodríguez Rodríguez I; Trujillo Armas R An Esp Pediatr; 1991 Mar; 34(3):225-9. PubMed ID: 2064152 [TBL] [Abstract][Full Text] [Related]
11. Urinary beta 2-microglobulin levels and urinary N-acetyl-beta-D-glucosaminidase enzyme activities in early diagnosis of non-insulin-dependent diabetes mellitus nephropathy. Mocan Z; Erem C; Yildirim M; Telatar M; Değer O Diabetes Res; 1994; 26(3):101-7. PubMed ID: 7621616 [TBL] [Abstract][Full Text] [Related]
12. Urinary excretion of beta 2-microglobulin and N-acetyl-beta-D-glucosaminidase in advanced neuroblastoma patients receiving cis-diamminedichloroplatinum(II). Ikeda H; Nagashima K; Okumura H; Takahashi A; Matsuyama S; Nagamachi Y Eur J Surg Oncol; 1988 Feb; 14(1):17-20. PubMed ID: 3278937 [TBL] [Abstract][Full Text] [Related]
13. Proximal tubule damage in patients treated with gentamicin or amikacin. Wiland P; Szechciński J Pol J Pharmacol; 2003; 55(4):631-7. PubMed ID: 14581723 [TBL] [Abstract][Full Text] [Related]
14. [Urinary N-acetyl-beta-D-glucosaminidase and incipient diabetic nephropathy]. Wang XD Zhonghua Yi Xue Za Zhi; 1988 Apr; 68(4):215-7. PubMed ID: 3196940 [No Abstract] [Full Text] [Related]
15. Urinary N-acetyl-beta-D-glucosaminidase activity in type I diabetes mellitus. Mungan N; Yuksel B; Bakman M; Topaloglu AK; Ozer G Indian Pediatr; 2003 May; 40(5):410-4. PubMed ID: 12768043 [TBL] [Abstract][Full Text] [Related]
16. Serum cystatin C level for better assessment of glomerular filtration rate in cystic fibrosis patients treated by amikacin. Halacova M; Kotaska K; Kukacka J; Vavrova V; Kuzelova M; Ticha J; Prusa R J Clin Pharm Ther; 2008 Aug; 33(4):409-17. PubMed ID: 18613859 [TBL] [Abstract][Full Text] [Related]
17. Contribution of glycemic control to the levels of urinary N-acetyl-beta-D-glucosaminidase (NAG), total protein, beta 2-microglobulin and serum NAG in type 1 (insulin-dependent) diabetes mellitus without macroalbuminuria. Watanabe Y; Nunoi K; Maki Y; Nakamura Y; Fujishima M Clin Nephrol; 1987 Nov; 28(5):227-31. PubMed ID: 3322619 [TBL] [Abstract][Full Text] [Related]
18. [N-acetyl-beta-D-glucosaminidase (NAG) in the urine. An additional parameter for diagnosing the site of urinary tract infection]. Ring E; Erwa W; Zobel G Monatsschr Kinderheilkd; 1989 May; 137(5):280-3. PubMed ID: 2739666 [TBL] [Abstract][Full Text] [Related]
19. [Urine enzymes and low molecular weight proteins as indicators of diabetic nephropathy]. Jung K; Pergande M; Schimke E; Ratzmann KP Klin Wochenschr; 1989; 67 Suppl 17():27-30. PubMed ID: 2739355 [TBL] [Abstract][Full Text] [Related]
20. Urinary activities of cathepsin B, N-acetyl-beta-D-glucosaminidase, and albuminuria in patients with type 2 diabetes mellitus. Piwowar A; Knapik-Kordecka M; Fus I; Warwas M Med Sci Monit; 2006 May; 12(5):CR210-4. PubMed ID: 16641878 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]